• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Covalon's transparent
Pin It

Covalon Technologies Ltd. an advanced medical technologies company, announced its participation in the Infusion Nurses Society Visitors to Covalon’s booth  will have the opportunity to explore the Company’s innovative vascular access and infection control solutions first-hand and learn why many top hospitals are choosing Covalon solutions for their patients.

“One of our primary goals is to give patients a feeling of freedom during infusion treatments – freedom from the worry of painful dressing removals and skin injuries,” said Brent Ashton, Chief Executive Officer, Covalon. “Our dressings are unique due to their exceptional coverage, composition, and chemistry. Our state-of-the-art silicone-based vascular access dressings merge safety and efficacy with empathy, moving us closer to providing patient care that is as compassionate as it is effective.”

Not all vascular access dressings are made the same, and Covalon is excited to showcase more compassionate solutions at the Infusion Nurses Society Annual Meeting and Exhibition. The event brings together hundreds of infusion therapy professionals from all over the globe to learn about the latest improvements to patient care and see the newest products on the infusion market. It offers a unique opportunity for healthcare providers to engage with leading-technologies and enhance their practice with the latest innovations.

Covalon’s patented vascular access products include:

VALGuard® - a transparent, environmental barrier designed to protect catheter hubs and line connections from external contaminants and gross contamination, including body fluids and other secretions. It incorporates a quick-release pull strip for fast access to infusion hubs and for easy removal.

IV Clear® - the world’s only dual-antimicrobial vascular access dressing that offers complete transparency at and around the insertion site for easy daily assessment and utilizes gentle silicone adhesive technology to help protect skin from injuries.

CovaClear® IV – utilizes soft silicone adhesive technology to help protect patients from skin injuries, but does not incorporate antimicrobials, for use with patients who either do not require or cannot tolerate antimicrobials.

For more information please visit, www.covalon.com.

Company Name: Covalon Technologies Ltd
About Company: Covalon is a patient-driven medical device company, that provides innovative and cost-effective healthcare solutions for advanced wound care, infection control, and medical device coatings. Through a strong portfolio of patented technologies and solutions, we offer innovative, gentle and more compassionate options to aid patients on their healing journey. Our solutions are designed for patients and made for care providers. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) by developing products that are sold under Covalon’s name; and (ii) by developing and commercializing medical products for other medical companies under development and license contracts. The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTCQX Market under the symbol CVALF.
Person of Contact: Brian Pedlar